Introduction
CatSper channels (CatSper1-4) are named after the first putative cation channel of sperm (Quill et al., 2001; Ren et al., 2001). CatSpers are putative six-transmembrane (6TM1) voltage-gated Ca2+-permeant channels and seem to be specific to sperm cells. CatSper1 and 2 are each essential for the hyperactivation of sperm cell motility, which is required for fertility. Sequence identities among these CatSper family members range between 22 and 27% across the ion transport domain (Lobley et al., 2003).
Structural Features
All CatSpers are most closely related to the 6TM voltage-gated sodium channel (NaVBP) in bacteria, with the next closest relatives being the large mammalian CaV and NaV channel classes (Fig. 1). CatSpers have an S4 transmembrane segment with positively charged amino acids interspersed between every three amino acids. CatSper1 also contains a remarkable abundance of histidine residues in its amino terminus.
Functional Features
CatSper1 is localized to the plasma membrane of the sperm tail (Ren et al., 2001). Targeted disruption of the CatSper1 gene led to a male sterile phenotype in an otherwise normal mouse. Whereas the mating behavior, sperm count, and sperm cell morphology of the mutant mice were indistinguishable from those of the wild type, mutant sperm cells were sluggish, displayed reduced basal velocity, and lacked vigorous beating and bending in the tail region. Mutant sperm cells could not fertilize eggs with an intact zona pellucida but could fertilize eggs whose outer layers had been enzymatically removed (Ren et al., 2001). Further studies showed that CatSper1-null sperm cells could not be hyperactivated (Carlson et al., 2003). Interestingly, depolarization evoked an increase in intracellular Ca2+ in wild-type sperm cells but not in CatSper1-null sperm cells (Carlson et al., 2003). CatSper2-null mice and sperm cells have an indistinguishable phenotype from CatSper1-null mice. Male mice lacking CatSper2 were also sterile due to the absence of the hyperactivated motility needed for penetration of the extracellular matrix of the egg (Quill et al., 2003). In one study in humans, subfertile men with deficient sperm cell motility had significantly reduced expression of CatSper1 (Nikpoor et al., 2004). CatSper2 has been implicated by linkage analysis in human asthenoteratozoospermia (Avidan et al., 2003).
Recently, spermatazoa were patch-clamped, and the CatSper1-dependent current was shown to be an alkaline-potentiated, voltage-activated, calcium-selective channel (Kirichok et al., 2006). CatSpers have not yet been functional in numerous heterologous expression systems or spermatocytes, apparently because they are not targeted to the plasma membrane of nonsperm cells (Ren et al., 2001). Little is known about CatSpers3 and 4.
Two-Pore Channels
The two-pore channels TPC1 and TPC2 are putative cation-selective ion channels related to CatSper and transient receptor potential channels and, more distantly, to Nav and Cav channels. The TPCN1 (Hs.524763; Mm.114054) and N2 (Hs.503051; Mm.102235) genes encode proteins with two repeats of a 6TM domain. Each domain has a positively charged voltage sensor segment. TPC1 mRNA is detected at relatively high levels in kidney, liver, and lung, and immunohistochemistry of kidney shows that TPC1 was expressed in the inner medullary collecting ducts (Ishibashi et al., 2000). Neither TPC has been functionally expressed in heterologous cells to date, and no genetic data are available.
Tables 1, 2, 3, 4 list the attributes of CatSper1 through CatSper4, respectively.
CatSper1 channel
CatSper2 channel
CatSper3 channel
CatSper and TPC family tree. See “International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels” for more details.
Footnotes
-
↵1 Abbreviations: TM, transmembrane; TPC, two-pore channel.
-
The authors are members of the Subcommittee on Transient Receptor Potential Channels of the Nomenclature Committee of the International Union of Pharmacology.
-
Article, publication date, and citation information can be found at http://pharmrev.aspetjournals.org.
-
doi:10.1124/pr.57.4.7.
- The American Society for Pharmacology and Experimental Therapeutics